Stroke history and Chagas disease are independent predictors of silent cerebral microembolism in patients with congestive heart failure

Cerebrovascular Diseases

Volumn 31, Issue 1, 2010, Pages 19-23

  Jesus, Pedro A P ^a   Neville, Iuri ^a,b   Cincurá, Carolina ^a   Menezes, Daniela F ^a   Vieira De Melo, Rodrigo M ^a   Lacerda, Amanda M ^a   Viana, Leila C ^a   Pereira, Davidson F ^a   Ribeiro Dos Santos Jr , Valter ^a,b   Reis, Francisco J F B ^a   Macedo, Cristiano ^a   Oliveira Filho, Jamary ^a,b  

^a FEDERAL UNIVERSITY OF BAHIA   (Brazil)

^b National Institute of Science and Technology in Tropical Diseases   (Brazil)

Author keywords

Chagas disease; Congestive heart failure; Stroke; Transcranial Doppler

Indexed keywords

ANTITHROMBOCYTIC AGENT;

ADULT; AGE; AGED; ANAMNESIS; ARTICLE; BRAIN EMBOLISM; CEREBRAL MICROEMBOLISM; CHAGAS DISEASE; CONGESTIVE HEART FAILURE; FEMALE; HEART LEFT VENTRICLE EJECTION FRACTION; HUMAN; MAJOR CLINICAL STUDY; MALE; MIDDLE CEREBRAL ARTERY; PACEMAKER; PRIORITY JOURNAL; STROKE;

ADULT; AGED; BRAZIL; CEREBROVASCULAR CIRCULATION; CHAGAS CARDIOMYOPATHY; CHAGAS DISEASE; FEMALE; HEART FAILURE; HOSPITALS, UNIVERSITY; HUMANS; INTRACRANIAL EMBOLISM; LOGISTIC MODELS; MALE; MIDDLE AGED; MIDDLE CEREBRAL ARTERY; ODDS RATIO; RISK ASSESSMENT; RISK FACTORS; STROKE; ULTRASONOGRAPHY, DOPPLER, TRANSCRANIAL;

EID: 77958511411     PISSN: 10159770     EISSN: None     Source Type: Journal    
DOI: 10.1159/000319892     Document Type: Article

References (24)

1. Control of Chagas' disease: Second Report of the WHO Expert Committee. Technical Report Series 905. Geneva, World Health Organization, 2002.
2. Andrade ZA, Sadigursky M: Trombo-embolismo em chagásicos sem insuficiência cardíaca. Gaz Méd Bahia 1971;71:59-64.
3. Arteaga-Fernandez E, Barreto AC, Ianni BM, Mady C, Lopes EA, Viana C D E B, Bellotti G, Pileggi F: Cardiac thrombosis and embolism in patients having died of chronic Chagas cardiopathy. Arq Bras Cardiol 1989;52:189-192.
4. Sousa AS, Xavier SS, Freitas GR, Hasslocher-Moreno A: Prevention strategies of cardioembolic ischemic stroke in Chagas' disease. Arq Bras Cardiol 2008;91:280-284.
5. Carod-Artal FJ, Vargas AP, Horan TA, Nunes LG: Chagasic cardiomyopathy is independently associated with ischemic stroke in Chagas disease. Stroke 2005;36:965-970.
6. Oliveira-Filho J, Viana LC, Melo R M V, Faiçal F, Torreão JA, Villar F A G A, Reis F J F B: Chagas disease is an independent risk factor for stroke: baseline characteristics of a Chagas cardiomyopathy cohort. Stroke 2005;36:2015-2017.
7. Paixão LC, Ribeiro LC, Valacto RA, Teixeira AL: Chagas' disease: independent risk factor for stroke. Stroke 2009;40:3691-3694.
8. Tong DC, Bolger A, Alder GW: Incidence of transcranial Doppler-detected cerebral microemboli in patients referred for echocardiography. Stroke 1994;25:2138-2141.
9. Censori B, Partziguiant T, Casto L, Camarlingo M, Mamoli A: Doppler microembolic signals predict ischemic recurrences in symptomatic carotid stenosis. Acta Neurol Scand 2000;101:327-331.
10. Junghans U, Siebler M: Cerebral microembolism is blocked by tirofiban, a selective nonpeptide platelet glycoprotein IIb/IIIa receptor antagonist. Circulation 2003;107:2717-2721.
11. Goertler M, Baeumer M, Kross R, Blaser T, Lutze G, Jost S, Wallesch CW: Cessation of embolic signals after antithrombotic prevention is related to reduced risk of recurrent arterioembolic transient ischaemic attack and stroke. J Neurol Neurosurg Psychiatry 2002;72:338-342.
12. King A, Markus HS: Doppler embolic signals in cerebrovascular disease and prediction of stroke risk: systematic review and metaanalysis. Stroke 2009;40:3711-3717.
13. McKee PA, Castelli WP, McNamara PM, Kannel WB: The natural history of congestive heart failure: the Framingham Study. N Engl J Med 1971;285:1441-1446.
14. Ringelstein EB, Babikian VL, Evans DH, Grosset DG, Kaps M, Markus HS, Russell D, Siebler M: Consensus of cerebral microembolism in acute microembolus detection by TCD. Stroke 1998;29:725-729.
15. Rassis-Junior A, Rassi A, Little WC, Xavier SS, Rassi SG, Rassi AG, Rassi GG, Hasslocher-Moreno A, Sousa AS, Scanavacca MI: Development and validation of a risk score for predicting death in Chagas' heart disease. N Engl J Med 2006;355:799-808.
16. Valton L, Larrue V, Traon AP, Massabuau P, Geraud G: Microembolic signals and risk of early recurrence in patients with stroke or transient ischemic attack. Stroke 1998;29:2125-2128.
17. Wijman C A C, Babikian VL, Matjucha I C A: Cerebral microembolism in patients with retinal ischemia. J Neurol Neurosurg Psychiatry 1997;63:784-787.
18. Nabavi DG, Arato S, Droste DW, Schulte-Altendonebourg G, Kemeny V, Reinecke H, Borggrefe M, Breithardt G, Ringelstein EB: Microembolic load in asymptomatic patients with cardiac aneurysm, severe left ventricular dysfunction and atrial fibrillation. Cerebrovasc Dis 1998;8:214-221.
19. Aras R, Da-Matta DA, Mota G, Gomes I, Melo A: Cerebral infarction in autopsies of chagasic patients with heart failure. Arq Bras Cardiol 2003;81:414-416.
20. Loh E, Sutton MS, Wun CC, Rouleau JL, Flaker GC, Gottlieb SS, Lamas GA, Moyé LA, Goldhaber SZ, Pfeffer MA: Ventricular dysfunction and the risk of stroke after myocardial infarction. N Engl J Med 1997;336:251-257.
21. Dries DL, Rosenberg YD, Waclatiw MA, Domanski MJ: Ejection fraction and risk of thromboembolic events in patients with systolic dysfunction and sinus rhythm: evidence for gender differences in the studies of left ventricular dysfunction trials. J Am Coll Cardiol 1997;29:1074-1080.
22. Zurab G, Nadareishvili Z, Choudary Z, Joyner C, Brodie D, Worris J: Cerebral microembolism in acute myocardial infarction. Stroke 1999;30:2679-2682.
23. Oliveira-Filho, Vieira-de-Melo RM, Reis P S O, Lacerda AM, Neville IS, Cincurá C, Menezes DF, Jesus P A P, Lopes AA, Reis FJ, Furie KL: Chagas disease is independently associated with brain atrophy. J Neurol 2009;256:1363-1365.
24. Kelley RE, Namon RA, Mantelle LL, Chang JY: Sensitivity and specificity of transcranial Doppler ultrasonography in the detection of high-grade carotid stenosis. Neurology 1993;43:1187-1191.